Evercore ISI lowered the firm’s price target on Avantor (AVTR) to $8.50 from $10 and keeps an In Line rating on the shares as part of the firm’s medical technology and life science tools Q1 preview.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR:
- ESAB says R. Brent Jones to succeed Kevin Johnson as CFO
- Avantor Announces CFO Resignation and Interim Finance Leadership
- Avantor says CFO R. Brent Jones to leave company on, before June 24
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Marvell upgraded, Trade Desk downgraded: Wall Street’s top analyst calls